On the morning of July 16th, the 4th "Tongxin Dream Building · Innovative Development" Forum Summit, hosted by Suzhou Linaxin Biotechnology Co., Ltd. and co organized by Qingmiao Science and Technology Innovation, was held in Kunshan. Bringing together over 100 experts, scholars, and entrepreneurs from all over the country, we have discussed and collaborated to promote healthy development and discuss the future of the gene oncology industry. Together, we aim to contribute to the construction of a Healthy China by 2030, uphold integrity, and innovate.

Lu Zuhong, director of the State Key Laboratory of Bioelectronics of Southeast University, Feng Weiqing, director of the Kunshan Huaqiao Science and Technology Bureau, Yin Jifu, director of the Yinan County Bureau of Commerce of Linyi City, Lu Zuhong, director of the State Key Laboratory of Bioelectronics of Southeast University, Lin Ligong, vice president of the Suzhou Shandong Chamber of Commerce, Teng Xiangnong, secretary of the Department of Sports and Health of Linyi University, Xu Yuping, chairman of the board of supervisors of the China Medical Materials Association, Zhou Huijun, director of the digestive department of Xiangya Medical College of Hunan Cancer Hospital, Tan Shengwei, general manager of Lina Core Biology, and Zhu Wanjie, deputy general manager of Lina Core Biology attended the conference.

At the beginning of the conference, Dr. Tan Shengwei, founder of Linaxin Biotechnology, expressed sincere gratitude to all the guests for their attendance. She said that in the vibrant July, more than 100 experts, scholars, and entrepreneurs from all over the country gathered together, and it was a great pleasure to meet new and old friends in Kunshan and gather at the "Building Dreams with the Same Core · Innovative Development" conference.

Feng Weiqing, Director of Kunshan Huaqiao Science and Technology Bureau, Lin Ligong, Vice President of Suzhou Shandong Chamber of Commerce, and Huan Qiong, President of Suzhou Bank Kunshan High tech Development Zone Branch, successively took the stage to deliver speeches, congratulating on the holding of this summit and putting forward earnest expectations for future development.

In addition, Tan Weifeng, vice president of Sichuan Zhenghexiang Health Pharmacy Chain Co., Ltd., on behalf of the strategic investor, said that he was very optimistic about the technical advantages and product layout of Linasin in the fields of nanopore sequencer, home health self inspection and cancer screening. Zhenghexiang will fully open up the big health industry ecosystem of "Internet plus+pharmacy+medical treatment" to Linasin, and comprehensively achieve in-depth cooperation.

At this innovation and development conference, Linaxin released the latest data on the layout and data of the cancer early screening system, the development of the nanopore gene detector prototype, and the early screening data for thousands of miles. And signed contracts for cooperative projects, strategic investments, and bank strategic cooperation.

The postgraduate internship base of Southeast University was officially launched in Suzhou Linasin Biotechnology Co., Ltd., an international innovation port in Kunshan Huaqiao. Dr. Tan Shengwei, the founder of Linasin, an alumnus of Southeast University, and Professor Lu Zuhong, the director of the State Key Laboratory of Bioelectronics of Southeast University jointly inaugurated the postgraduate internship base of Southeast University, realizing that the university and enterprises work together to build a highland for gathering industry, university and research talents.

In addition, at this innovation and development conference, Linaxin launched a prospective clinical research on tumor early screening products and the development of engineering prototypes for nanopore gene detection devices. The launch of this project marks a further enhancement of Linaxin's technological strength and innovation capabilities in the biomedical field, which will bring more breakthrough technological achievements to the human health cause.

At this conference, Director Zhu Haitao from Jiangsu Cancer Hospital discussed the trends in tumor early screening and technology development, Professor Liu Quanjun from Southeast University discussed the innovative development of nanopore technology in scientific research and clinical practice, and Xu Yuping, Chairman of China Medical Materials Association and Chairman of Jiangsu Jiahuitang Co., Ltd., discussed the future development of home self inspection and cancer early screening products in retail pharmacies.

This academic forum provides an important communication platform for the development of early screening of tumors and related technologies. The 4th "Tongxin Building Dreams and Innovative Development" Forum Summit provides a platform for in-depth communication and cooperation within and outside the industry. We believe that with the joint efforts of all parties, we will jointly promote the development of early screening for tumors and contribute to a Healthy China by 2030!